HUE063768T2 - Kurkumint és további hatóanyagként legalább egy kannabinoidot tartalmazó szolubilizátum - Google Patents

Kurkumint és további hatóanyagként legalább egy kannabinoidot tartalmazó szolubilizátum

Info

Publication number
HUE063768T2
HUE063768T2 HUE19736404A HUE19736404A HUE063768T2 HU E063768 T2 HUE063768 T2 HU E063768T2 HU E19736404 A HUE19736404 A HU E19736404A HU E19736404 A HUE19736404 A HU E19736404A HU E063768 T2 HUE063768 T2 HU E063768T2
Authority
HU
Hungary
Prior art keywords
solubilisate
cannabinoid
curcumin
active agent
further active
Prior art date
Application number
HUE19736404A
Other languages
English (en)
Inventor
Dariush Behnam
Original Assignee
Aquanova Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2017/067382 external-priority patent/WO2019011415A1/de
Priority claimed from PCT/EP2017/067381 external-priority patent/WO2019011414A1/de
Priority claimed from DE102017115496.5A external-priority patent/DE102017115496A1/de
Application filed by Aquanova Ag filed Critical Aquanova Ag
Publication of HUE063768T2 publication Critical patent/HUE063768T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
HUE19736404A 2017-07-11 2019-07-10 Kurkumint és további hatóanyagként legalább egy kannabinoidot tartalmazó szolubilizátum HUE063768T2 (hu)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/EP2017/067382 WO2019011415A1 (de) 2017-07-11 2017-07-11 SOLUBILISAT MIT CURCUMIN, XANTHOHUMOL UND SÜßHOLZWURZELEXTRAKT
PCT/EP2017/067381 WO2019011414A1 (de) 2017-07-11 2017-07-11 Solubilisat mit curcumin und boswellia
DE102017115496.5A DE102017115496A1 (de) 2017-07-11 2017-07-11 Süßholzwurzelextrakt-Solubilisat
PCT/EP2018/068731 WO2019011955A2 (de) 2017-07-11 2018-07-11 Solubilisat mit curcumin und optional zumindest einem weiteren wirkstoff

Publications (1)

Publication Number Publication Date
HUE063768T2 true HUE063768T2 (hu) 2024-02-28

Family

ID=62837944

Family Applications (4)

Application Number Title Priority Date Filing Date
HUE18738321A HUE064518T2 (hu) 2017-07-11 2018-07-11 Kurkumint és legalább egy további hatóanyagot tartalmazó szolubilizátum
HUE18737623A HUE063380T2 (hu) 2017-07-11 2018-07-11 Szolubilizátum Kurkuminnal, Boswellia-val és Xantohumollal
HUE19736404A HUE063768T2 (hu) 2017-07-11 2019-07-10 Kurkumint és további hatóanyagként legalább egy kannabinoidot tartalmazó szolubilizátum
HUE19736735A HUE063382T2 (hu) 2017-07-11 2019-07-10 Szolubilizátum kurkuminnal és további hatóanyagként legalább a THC kannabinoiddal

Family Applications Before (2)

Application Number Title Priority Date Filing Date
HUE18738321A HUE064518T2 (hu) 2017-07-11 2018-07-11 Kurkumint és legalább egy további hatóanyagot tartalmazó szolubilizátum
HUE18737623A HUE063380T2 (hu) 2017-07-11 2018-07-11 Szolubilizátum Kurkuminnal, Boswellia-val és Xantohumollal

Family Applications After (1)

Application Number Title Priority Date Filing Date
HUE19736735A HUE063382T2 (hu) 2017-07-11 2019-07-10 Szolubilizátum kurkuminnal és további hatóanyagként legalább a THC kannabinoiddal

Country Status (19)

Country Link
US (8) US11344509B2 (hu)
EP (2) EP3651804B1 (hu)
JP (1) JP2020529974A (hu)
KR (1) KR20200029002A (hu)
CN (2) CN111201041A (hu)
BR (1) BR112020000398A2 (hu)
CA (2) CA3148455A1 (hu)
DK (3) DK3651804T5 (hu)
ES (3) ES2965739T3 (hu)
FI (2) FI3651804T3 (hu)
HR (3) HRP20231591T1 (hu)
HU (4) HUE064518T2 (hu)
MX (2) MX2021000339A (hu)
PL (3) PL3651805T3 (hu)
PT (2) PT3651804T (hu)
RS (3) RS64650B1 (hu)
RU (2) RU2752078C1 (hu)
UA (1) UA125552C2 (hu)
WO (3) WO2019011954A1 (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020000398A2 (pt) 2017-07-11 2020-07-14 Aquanova Ag solubilizado com curcumina e, opcionalmente, pelo menos umas outras substâncias ativas
PL3820527T3 (pl) 2018-07-11 2024-01-03 Aquanova Ag Solubilizator ksantohumolu
DE202019104734U1 (de) * 2019-08-29 2020-12-01 Aquanova Ag Folsäure-Solubilisat
WO2023282783A1 (ru) * 2021-07-09 2023-01-12 Акционерное Общество "Акванова Рус" Мицеллированный раствор активного компонента на основе экстракта лакрицы, способ его получения и применения
WO2023224134A1 (ko) * 2022-05-16 2023-11-23 주식회사 다미래 수용화 커큐민과 보스웰리아 추출물을 이용한 인지 능력 개선용 조성물

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07165588A (ja) 1993-12-13 1995-06-27 Tsumura & Co 脳機能改善剤
US5744161A (en) 1995-02-24 1998-04-28 Sabinsa Corporation Use of piperine as a bioavailability enhancer
US5629351A (en) 1995-04-13 1997-05-13 Council Of Scientific & Industrial Research Boswellic acid compositions and preparation thereof
EP1358876B1 (de) 2002-04-30 2007-11-07 Cognis IP Management GmbH Mikrokapseln mit Anti-Aknewirkstoffen
ES2258200T3 (es) * 2002-12-18 2006-08-16 Dohler Gmbh Bebida que contiene xantohumol.
WO2005092352A1 (fr) 2004-03-26 2005-10-06 Jianzhong Zhu Procede de production utilisations de preparation liposomique de medecine chinoise pour le traitement de l'hepatite b virale et pour la prevention et le traitement de la fibration des cellules hepatiques
US20080220102A1 (en) 2005-07-08 2008-09-11 Dariush Behnam Solubilsation Products of an Active Ingredient Extract
DE102006024911A1 (de) 2006-05-24 2007-11-29 Aquanova Ag Boswellinsäure-Konzentrat
DK1903866T3 (en) 2005-11-07 2016-07-25 Murty Pharmaceuticals Inc Improved release of tetrahydrocannabinol
WO2007058480A1 (en) 2005-11-16 2007-05-24 Md Bioalpha Co., Ltd. Composition having effect on treatment and prevention of diseases syndrome treatment with glabridin
TW200806306A (en) 2006-02-24 2008-02-01 Kaneka Corp Oil-in-water emulsion composition containing licorice-derived polyphenol
TW200808333A (en) 2006-04-17 2008-02-16 Kaneka Corp Licorice polyphenol preparation
GB0623838D0 (en) 2006-11-29 2007-01-10 Malvern Cosmeceutics Ltd Novel compositions
DE102006062264A1 (de) 2006-12-22 2008-06-26 Joh. Barth & Sohn Gmbh & Co. Kg Verwendung von Xanthohumol zur Vorbeugung und/oder Bekämpfung von Lebererkrankungen
US9241893B2 (en) 2007-11-19 2016-01-26 Stiefel Laboratories, Inc. Topical cosmetic skin lightening compositions and methods of use thereof
WO2009126320A1 (en) 2008-04-11 2009-10-15 Betal, Llc Xanthohumol compositions and methods for treating skin diseases or disorders
ES2316312B1 (es) 2008-06-20 2010-02-08 Ignacio Umbert Millet Composicion farmaceutica dermatologica para el tratamiento de patologias de inflamacion de la piel, tales como por ejemplo dermatitis, dermatitis atopica, vitiligo, alopecia areata, acne, psoriasis y prurito,y combinaciones de las mismas.
EP2192160B1 (de) 2008-12-01 2016-08-17 Aquanova Ag Micellar integrierter Oxidationsschutz für natürliche Farbstoffe
US20110086017A1 (en) 2009-10-08 2011-04-14 Svetlana Kravets Medical Food composition and methods for management of inflammatory processes in mammals
CN103298443B (zh) 2011-01-06 2015-06-17 花王株式会社 水包油型乳化组合物
US8808734B2 (en) * 2011-07-11 2014-08-19 Full Spectrum Laboratories Limited Cannabinoid formulations
DE202012012130U1 (de) * 2012-12-19 2014-03-21 Aquanova Ag Curcuminsolubilisat
US10213391B2 (en) 2014-05-06 2019-02-26 Mewa Singh Pharmaceutical compositions comprising hemp and turmeric to treat pain and inflammation
US20160008298A1 (en) 2014-07-14 2016-01-14 Oregon State University Xanthohumol-based compounds and compositions thereof, and methods of making and using the same
WO2016022936A1 (en) 2014-08-07 2016-02-11 Murty Pharmaceuticals, Inc. An improved oral gastrointestinal dosage form delivery system of cannabinoids and/or standardized marijuana extracts
US20160081975A1 (en) 2014-09-18 2016-03-24 Virun, Inc. Soft gel compositions and pre-gel concentrates
US20170333515A1 (en) * 2015-11-10 2017-11-23 Eric H. Kuhrts Compositions and methods for enhancing the metabolic activity or stability of curcumin
IL248149B (en) 2016-09-29 2020-03-31 Garti Nissim Formulations of dilutable cannabinoids and processes for their preparation
CN106619588B (zh) * 2016-12-29 2019-08-16 厦门金达威生物科技有限公司 一种含辅酶q10的自微乳型营养组合物、制备方法及用途
GB2559774B (en) * 2017-02-17 2021-09-29 Gw Res Ltd Oral cannabinoid formulations
WO2019011415A1 (de) 2017-07-11 2019-01-17 Aquanova Ag SOLUBILISAT MIT CURCUMIN, XANTHOHUMOL UND SÜßHOLZWURZELEXTRAKT
BR112020000398A2 (pt) 2017-07-11 2020-07-14 Aquanova Ag solubilizado com curcumina e, opcionalmente, pelo menos umas outras substâncias ativas

Also Published As

Publication number Publication date
HUE064518T2 (hu) 2024-03-28
MX2021000339A (es) 2021-03-25
WO2019011955A2 (de) 2019-01-17
PT3651804T (pt) 2023-10-18
DK3651805T3 (da) 2023-12-11
EP3651805A2 (de) 2020-05-20
EP3651805B1 (de) 2023-10-25
WO2019011990A1 (de) 2019-01-17
DK3651804T5 (da) 2023-10-09
CN111163806A (zh) 2020-05-15
CA3069621A1 (en) 2019-01-17
FI3820528T3 (en) 2023-10-17
KR20200029002A (ko) 2020-03-17
RS64636B1 (sr) 2023-10-31
PT3651805T (pt) 2023-12-22
US20220249400A1 (en) 2022-08-11
US20220133682A1 (en) 2022-05-05
US20220125741A1 (en) 2022-04-28
WO2019011955A3 (de) 2019-05-16
ES2965739T3 (es) 2024-04-16
WO2019011954A1 (de) 2019-01-17
MX2021000385A (es) 2021-03-25
DK3651804T3 (da) 2023-09-25
RS64650B1 (sr) 2023-10-31
BR112020000398A2 (pt) 2020-07-14
US11931322B2 (en) 2024-03-19
HRP20231160T1 (hr) 2024-01-05
DK3820528T3 (da) 2023-10-16
ES2960689T3 (es) 2024-03-06
FI3651804T3 (en) 2023-10-04
CN111201041A (zh) 2020-05-26
HRP20231135T1 (hr) 2024-01-05
JP2020529974A (ja) 2020-10-15
US20240325318A1 (en) 2024-10-03
EP3651804B1 (de) 2023-08-23
PL3651805T3 (pl) 2024-04-08
EP3651804A1 (de) 2020-05-20
CA3148455A1 (en) 2019-01-17
ES2960296T3 (es) 2024-03-04
PL3651804T3 (pl) 2024-01-03
RU2752078C1 (ru) 2021-07-22
RU2771527C1 (ru) 2022-05-05
US20240216297A1 (en) 2024-07-04
CA3069621C (en) 2022-05-03
US11197834B2 (en) 2021-12-14
US20200222346A1 (en) 2020-07-16
HUE063382T2 (hu) 2024-01-28
US20200129452A1 (en) 2020-04-30
US11344509B2 (en) 2022-05-31
US20220133646A1 (en) 2022-05-05
HUE063380T2 (hu) 2024-01-28
PL3820529T3 (pl) 2024-01-03
UA125552C2 (uk) 2022-04-13
HRP20231591T1 (hr) 2024-03-15
RS64642B1 (sr) 2023-10-31

Similar Documents

Publication Publication Date Title
HUE063768T2 (hu) Kurkumint és további hatóanyagként legalább egy kannabinoidot tartalmazó szolubilizátum
PL3820528T3 (pl) Solubilizator z kurkuminą i co najmniej jednym kannabinoidem jako dodatkową substancją czynną
HUE054503T2 (hu) Arilazol vegyület és kártevõ elleni szer
HK1243997B (zh) Kv1．3抑制劑及其醫學應用
IL287929A (en) Cannabinoids and their uses
SG11201803669UA (en) Microorganism-controlling agent and miticidal composition
IL278881A (en) Cannabinoids and their use
IL269305A (en) Cannabinoid formulations and dosage
EP3515758A4 (en) LEVER TENSIONERS AND OVERLOAD INDICATORS
IL273967A (en) Aqueous preparations containing bilastin and methotrexate
HK1243998A1 (zh) Kv1．3抑制劑及其醫學應用
GB201707469D0 (en) Antimicrobial and antifungal agent
EP3601246C0 (en) 16-METHYL-OXACYCLOHEXADECAN-2-ONE AND 16-METHYL-AZACYCLOHEXADECAN-2-ONE DERIVATIVES AS ANTIMICROBIAL AGENTS
GB201501474D0 (en) Agent, product and use